Title of Series
|
Issuer
|
CUSIP Numbers
|
9.00% Senior Notes due 2025
|
Bausch Health Companies Inc.
|
91911KAP7 / C94143AM3
|
9.25% Senior Notes due 2026
|
Bausch Health Americas, Inc.
|
91911XAV6 / U9098VAN2
|
8.50% Senior Notes due 2027
|
Bausch Health Americas, Inc.
|
91911XAW4 / U9098VAP7
|
5.00% Senior Notes due 2028
|
Bausch Health Companies Inc.
|
071734AH0 / C07885AD5
|
7.00% Senior Notes due 2028
|
Bausch Health Companies Inc.
|
071734AD9 / C07885AB9
|
5.00% Senior Notes due 2029
|
Bausch Health Companies Inc.
|
071734AM9 / C07885AH6
|
6.25% Senior Notes due 2029
|
Bausch Health Companies Inc.
|
071734AK3 / C07885AF0
|
7.25% Senior Notes due 2029
|
Bausch Health Companies Inc.
|
071734AF4 / C07885AC7
|
5.25% Senior Notes due 2030
|
Bausch Health Companies Inc.
|
071734AJ6 / C07885AE3
|
5.25% Senior Notes due 2031
|
Bausch Health Companies Inc.
|
071734AL1 / C07885AG8
|
The transaction will be available only to the following holders of Existing Senior Notes (collectively, “Eligible Holders”):
(a) persons who are reasonably believed to be “qualified institutional buyers” as defined in Rule 144A under the Securities Act
of 1933, as amended (the "Securities Act") that are also “qualified purchasers” (as defined in Section 2(a)(51) of the U.S. Investment Company Act of 1940, as amended)
in a transaction not involving
a public offering, pursuant to
Section 4(a)(2) of the Securities Act, or
(b) persons other than “U.S. persons” as defined in Regulation S, outside of the United States, and who are otherwise in
compliance with the requirements of Regulation S;
provided that, in each case, if such holder
(i) is resident in Canada, such holder is required to complete,
sign and submit to the Information Agent a “Canadian Holder Form”, which may be obtained from the Information Agent, or
(ii) is in the European Economic Area or the United Kingdom, such holder is not a “retail investor”.
To receive further information, please complete the attached eligibility letter and return it to D.F. King & Co., Inc., as information agent
(the “Information Agent”), at the address set forth therein.
PLEASE RESPOND NO LATER THAN 11:59 P.M., NEW YORK CITY TIME, ON SEPTEMBER 27, 2022.
I am an "Eligible Holder"
I am not an "Eligible Holder"
You may direct any questions to D.F. King & Co., Inc., 48 Wall Street, 22nd Floor, New York, New York 10005, Attn: Michael Horthman,
Email: bhc@dfking.com, Telephone number: (212) 269-5550, (877) 478-5045 (toll-free).